FIMM Logo

Search form

  • FIMM
    • About FIMM
      • Annual Reports
      • Establishment
      • FIMM brochure 2017
      • FIMM in a nutshell
      • Management
      • What makes us special
    • Networks
      • EU-LIFE
      • Nordic EMBL Partnership
    • People
      • Senior Researchers
  • Research
    • Human Genomics
      • Ganna
      • Groop
      • Hennah
      • Kaprio
      • Ollikainen
      • Palotie
      • Pirinen
      • Ripatti
      • Saarela
      • Tukiainen
      • Vuoksimaa
      • Widen
    • Systems Biomedicine
      • Aittokallio
      • Heckman
      • Horvath
      • Kallioniemi
      • Lundin
      • Verschuren
      • Wennerberg
    • Grand Challenge Programmes
      • Digital Diagnostics for Precision Medicine
      • Genomics and Epidemiology to Understand and Predict Disease
      • Individualized Systems Medicine in Cancer
    • Publications
      • Publications 2019
      • Publications 2018
      • Publications 2017
      • Publications 2016
      • Publications 2015
      • Publications 2014
      • Publications 2013
      • FIMM Monthly Publication Highlights
    • Expert Groups
      • Imaging Experts
    • Ongoing Collaborative Projects
      • EU Research Projects
        • Hercules
        • Medbioinfomatics
      • ESFRI Projects
      • EU Infrastructure Projects
      • Personal genomics projects
    • Technology Transfer
  • Services
    • Biobanking Infrastructure
      • Meilahti Integrated Biobank Infrastructure
    • Technology Centre
      • Bioinformatics
      • Digital microscopy & molecular pathology
      • Extracellular Vesicles
      • Genotyping
      • High Content Imaging and Analysis
      • High Throughput Biomedicine (HTB)
      • IT
      • Metabolomics
      • Sequencing
      • Single Cell Analytics
    • DDCB Consortium
    • EATRIS Infrastructures
  • Training
    • Doctoral Training
      • FIMM-EMBL International PhD
      • FIMM Courses
      • FIMM Doctoral Training Committee
      • Dissertations
    • FIMMPOD Postdoctoral Program
      • FIMMPOD Events
      • FIMMPOD Components: Career Development
      • FIMMPOD Components: Mentoring
      • FIMMPOD Components: Recruitment
      • FIMMPOD Components: Social Events
      • FIMMPOD Components: Well-Being
    • Activities
      • FIMM PhD Student and Postdoc Council
      • FIMM Peer Mentoring in Soft Skills
      • FIMM Think Different Seminars
      • FIMM Young Investigator of Month
      • Scientific Coffee Breaks
    • Undergraduate training
  • Search
  • Contact
  • Media
  • News
  • Open positions
  • Events
  • Suomeksi
FIMM logo

Institute for Molecular Medicine Finland
Nordic EMBL Partnership for Molecular Medicine

Building a bridge from discovery to medicine

Research

Training

poster session

Services

News

19.03.2020

A high-resolution approach to multi-dimensional clonal phenomics

16.03.2020

COVID-19 Host Genetics Initiative

13.03.2020

FIMM is taking proactive measures regarding the COVID-19 outbreak

28.02.2020

Balaguru Ravikumar’s dissertation demonstrates the value of computational frameworks on interpreting large-scale drug screening data

27.02.2020

FinnGen wel­comes Janssen and Maze Thera­peut­ics

26.02.2020

FIMM meets Pharma 2020

17.02.2020

Novel bioin­form­at­ics tool en­ables iden­ti­fic­a­tion of drug com­bin­a­tions with in­creased po­ten­tial for clin­ical suc­cess

20.01.2020

Novel genetic variant with implications on heart failure pathogenesis identified

07.01.2020

Applications invited for the 2020 FIMM-EMBL/HIIT International PhD Programme

09.12.2019

Ma­chine learn­ing de­creases ex­per­i­men­tal costs of drug com­bin­a­tion screen­ing for trans­la­tional ap­plic­a­tions

Highlights

FinnGen wel­comes Janssen and Maze Thera­peut­ics

FinnGen, a large-scale academic – industry, genome research collaboration in Finland coordinated by FIMM researchers now includes eleven industry partners with the addition of the Janssen Pharmaceutical Companies of Johnson...

Ma­chine learn­ing de­creases ex­per­i­men­tal costs of drug com­bin­a­tion screen­ing for trans­la­tional ap­plic­a­tions

FIMM researchers have developed an efficient machine learning model that requires only a limited set of dose-response measurements for accurate prediction of drug combination synergy in a given patient sample. The minimal-input...

ASHG TV 2019: FIMM

WebsEdge/Health presents ASHG TV 2019. Highlights and conference news from The American Society of Human Genetics (ASHG) Annual Meeting - Sharing Discoveries. Shaping our Future

Dr. Katja Kivinen appointed new Head of the FIMM Technology Centre

Dr Katja Kivinen has been appointed new Head of the FIMM Technology Centre. She will start in this position on September 16, 2019. Dr. Kivinen has a wealth of expertise in both genetics and bioinformatics. Recently, she has...

DrugComb, a one-stop solution to all your cancer drug combination data analysis needs

Assistant Professor Jing Tang, a principal investigator of the Network Pharmacology group at FIMM and at the UH Faculty of Medicine has led the development of DrugComb, an open resource for harmonizing cancer drug combination...

Upcoming events

28.02.2020 Balaguru Ravikumar's Doctoral Defence

Balaguru Ravikumar will defend his doctoral dissertation entitled "Computational frameworks to aid pharmacological studies: Tools, Databases and Prediction models"

Latest publications

Identification of novel regulators of STAT3 activity. Read full article
Impact of enzymatic hydrolysis on the nutrients, phytochemicals and sensory properties of oil hemp seed cake (Cannabis sativa L. FINOLA variety). Read full article
Identification of slit3 as a locus affecting nicotine preference in zebrafish and human smoking behaviour. Read full article
In vivo assessment of functional and morphological alterations in tumors under treatment using OCT-angiography combined with OCT-elastography. Read full article
Machine learning algorithms performed no better than regression models for prognostication in traumatic brain injury. Read full article

Twitter feed

Tweets by FIMM_UH

EMBL

In close collaboration with:

HUS logo
FIMM

P.O. Box 20
FI-00014 University of Helsinki
FINLAND

Social Media

  • Facebook
  • Twitter
  • Vimeo
About FIMM

The mission of the Institute is to advance new fundamental understanding of the molecular, cellular and etiological basis of human diseases. This understanding will lead to improved means of diagnostics and the treatment and prevention of common health problems. Finnish clinical and epidemiological study materials will be used in the research. Learn more about FIMM.

About the website